[1] |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 12 7(12): 2893-917.
|
[2] |
Hagymási K, Tulassay Z. Risk factors for esophageal cancer, and possible genetic background[J]. Orv Hetil, 2009, 150(9): 407-13.
|
[3] |
Petroff MG, Perchellet A. B7 family molecules as regulators of the maternal immune system in pregnancy[J]. Am J Reprod Immunol, 20 10, 63(6): 506-19.
|
[4] |
Xiong XJ, Yang M, Fang DM, et al. Expression of B7 costimulator in human malignant hematological cell lines and its effects on activation of human peripheral blood T lymphocyte[J]. Mian Yi Xue Za Zhi, 2009, 25(6): 621-4.[熊秀娟, 杨铭, 范冬梅, 等. B7在 血液病细胞系中的表达及对T淋巴细胞的免疫反应[J]. 免疫学 杂志, 2009, 25(6): 621-4.]
|
[5] |
Loos M, Hedderich DM, Friess H, et al. B7-h3 and its role in antitumor immunity[J]. Clin Dev Immunol, 2010, 2010: 683875.
|
[6] |
Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production[J]. Nat Immunol, 20 01, 2(3): 269-74.
|
[7] |
Ling V, Wu PW, Spaulding V, et al. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss[J]. Genomics, 20 03, 82(3): 365-77.
|
[8] |
Sun M, Richards S, Prasad DV, et al. Characterization of mouse and human B7-H3 genes[J]. J Immunol, 2002, 168(12): 6294-7.
|
[9] |
Tran CN, Thacker SG, Louie DM, et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3[J]. J Immunol, 2008, 180(5): 2989-98.
|
[10] |
Suh WK, Gajewska BU, Okada H, et al. The B7 family member B7-H3 preferentially down-regulates T helper type1-mediated immune responses[J]. Nat Immunol, 2003, 4(9): 899-906.
|
[11] |
Prasad DV, Nguyen T, Li Z, et al. Murine B7-H3 is a negative regulator of T cells[J]. J Immunol, 2004, 173(4): 2500-6.
|
[12] |
Xu YH, Zhang GB, Wang JM, et al. Effect of B7-H3 on growth of lewis lung carcinoma cell[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39 (4): 376-80.[徐跃华, 张光波, 汪家敏, 等. B7-H3对小鼠Lewis 肺癌细胞生长的影响[J]. 肿瘤防治研究, 2012, 39(4): 376-80.]
|
[13] |
Wu CP, Jiang JT, Tan M, et al. Relationship between costimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis[J]. World J Gastroenterol, 2006, 12(3): 45 7-9.
|
[14] |
Sun Y, Wang Y, Zhao J, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer[J]. Lung Cancer, 2006, 53(2): 143-51.
|
[15] |
Arigami T, Narita N, Mizuno R, et al. B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis[J]. Ann Surg, 2010, 252(6): 1044-51.
|
[16] |
Roth TJ, Sheinin Y, Lohse CM, et al. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy[J]. Cancer Res, 2007, 67(16): 7893-900.
|
[17] |
Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome[J]. Science, 2006, 313(5795): 1960-4.
|
[18] |
Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer[J]. J Clin Oncol, 2011, 29(15): 1949-55.
|